Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Cerevance
3153
Cerevance
Technology
Biotechnology
Life Sciences
Cerevance is develops therapeutics for neurological and psychiatric disorders.
Suggest edits
Type
B2c
Founded
2016
Raised
$81M
Companies in the same industry
MIP Diagnostics
Elevation Oncology Inc.
Genemod
Vaxess Technologies
Diagenode
Tetra Discovery Partners, Inc.
Antibodies.com
Lyncean Technologies Inc.
Hennepin Life Sciences
Diasome
Overview
Funding
2
Add info
Latest funding
$45,000,000
Venture capital (Series B) - 2020
Foresite Capital
GV
Lightstone Ventures
+3
$36,000,000
Venture capital (Series A) - 2016
Takeda Pharmaceutical
Lightstone Ventures
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
$45,000,000
Venture capital (Series B)
Xconomy
Cerevance Raises $45M to Advance Brain Disease Research & Development
$36,000,000
Venture capital (Series A)
takeda
CEREVANCE LAUNCHED WITH NEW TECHNOLOGY, DRUG PORTFOLIO AND $36M IN CASH TO TACKLE BRAIN DISEASES Pharmaceutical Company...